Clinical Focus
Business Focus
Spotlight
Subscribe
CE/CME
- CDC
- Heart Failure
- Cardiovascular Clinical Consult
- Adult Immunization
- Hepatic Disease
- Rare Disorders
- Pediatric Immunization
- Implementing The Topcon Ocular Telehealth Platform
- Weight Management
- Screening
- Monkeypox
- Guidelines
- Men's Health
- Psychiatry
- Allergy
- Nutrition
- Women's Health
- Cardiology
- Substance Use
- Pediatrics
- Kidney Disease
- Genetics
- Complimentary & Alternative Medicine
- Dermatology
- Endocrinology
- Oral Medicine
- Otorhinolaryngologic Diseases
- Pain
- Gastrointestinal Disorders
- Geriatrics
- Infection
- Musculoskeletal Disorders
- Obesity
- Rheumatology
- Technology
- Cancer
- Nephrology
- Anemia
- Neurology
- Pulmonology
The 2024 COPD GOLD Report: A Guideline Topline, Part 1
Updates in the Global Initiative for Obstructive Lung Disease report include using spirometry values in diagnosis and optimizing inhaled pharmacotherapy.
The 2024 Global Initiative for Obstructive Lung Disease (GOLD) report provides several updates in the diagnosis and management of chronic obstructive pulmonary disease (COPD) after the major revisions made in 2023.
Above is part 1 of our GOLD Report guideline topline slideshow, which summarizes the updates for a quick, at-a-glance review. Click through these topline notes on best practices in use of spirometry for diagnosis of COPD, confirming spirometry results, and the GOLD grades for COPD severity based on measured airflow obstruction.
Recent Videos
Related Content
